[Tardive dyskinesia and the therapeutic agents].
Nomoto
M
M
D000818:Animals; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects; D015259:Dopamine Agents / Q000009:adverse effects; D004409:Dyskinesia, Drug-Induced / Q000145:classification / Q000503:physiopathology; D006801:Humans; D007980:Levodopa / Q000009:adverse effects
D018726:Anti-Dyskinesia Agents; D014150:Antipsychotic Agents; D015259:Dopamine Agents; D007980:Levodopa